Investments in digital technology, according to experts in the biological sciences, would hasten innovation and efficiency. Here, conferences like the Global Tech Summit 2023, which will take place in Visakhapatnam from February 16–17, are positioned as the perfect venue for discovering new technologies in drug research and lowering the cost of medications.
Recently, the Global Tech Summit team held a roadshow and meeting on business-to-biopharma digital transformation in Nagpur, which served as the location of the recently concluded 72nd Indian Pharmaceutical Congress, which was held from January 20–22, 2023. The meeting was led by Dr. Srinubabu Gedela, CEO, Pulsus Group.
The International Pharmaceutical Federation's President, Dr. Dominique Jordan, emphasized the potential influence of technology on the future of drug research. According to him, "digital technologies are being implemented in the pharmaceutical business to enhance the manufacturing and delivery of healthcare products and services.
Dr. Jordan said, "Digital transformation for the pharmaceutical business may increase supply chain transparency, reduce carbon footprint, and improve medication research and patient care."
Dr. Atul Nasa, president of the Indian Pharma Graduates Association, said, "Artificial I and ML can help accelerate drug discovery by analyzing large amounts of data and identifying potential drug candidates quickly and efficiently."
"Regulators must find a balance between encouraging innovation and protecting public health," said Dr. H.G. Koshla, Commissioner of Food and Drug Control Administration, Government of Gujarat.
Abhijit Ghosh, assistant drug controller, medical device, CDSCO said "Digital transformation is inevitable, and India should take the lead in developing policies that encourage innovation while protecting public health".
Dr. T V Narayana, president of the Indian Pharmaceutical Association, emphasized the importance of the pharma industry and academic-industry collaboration, He stated that combining the financial backing of pharma companies with early-stage drug molecules from academic institutions is a key source of innovation, with many successful assets being developed and commercialized through institutional technology out-licensing.
Global Tech Summit
Posted on: Feb 13, 2023
